1
TITLE: HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naive patients with chronic hepatitis C virus genotype-1b infection
AUTHORS: Christoph Sarrazin; Francesco Castelli; Pietro Andreone; Maria Buti; Massimo Colombo; Stanislas Pol; Filipe Calinas; Massimo Puoti; Antonio Olveira; Mitchell Shiffman; Jerry O Stern; George Kukolj; Michael Roehrle; Stella Aslanyan; Qiqi Q Deng; Richard Vinisko; Federico J Mensa; David R Nelson;
PUBLISHED: 2016, SOURCE: CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, VOLUME: 9
INDEXED IN: Scopus WOS
2
TITLE: HCVerso2: A phase III study of faldaprevir (FDV) plus deleobuvir (DBV) and ribavirin (RBV) for chronic HCV genotype (GT)-1b infection in treatment-naive patients including those ineligible for pegylated interferon (PegIFN)
AUTHORS: David R Nelson; Pietro Andreone; Massimo Colombo; Filipe Calinas; Antonio Olveira; Jean Delwaide; Dieter Haeussinger; Denis Ouzan; Simone I Strasser; Tarik Asselah; Curtis Cooper; Jerry O Stern; Wulf O Boecher; George Kukolj; Stella Aslanyan; Qiqi Q Deng; Edward Wang; Federico J Mensa;
PUBLISHED: 2014, SOURCE: 65th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases in HEPATOLOGY, VOLUME: 60
INDEXED IN: WOS